Short Interest in Heart Test Laboratories, Inc. (NASDAQ:HSCS) Rises By 343.2%

Heart Test Laboratories, Inc. (NASDAQ:HSCS) saw a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 599,600 shares, a growth of 343.2% from the March 31st total of 135,300 shares. Currently, 1.1% of the shares of the stock are sold short. Based on an average trading volume of 1,920,000 shares, the days-to-cover ratio is presently 0.3 days.

Institutional Investors Weigh In On Heart Test Laboratories

An institutional investor recently raised its position in Heart Test Laboratories stock. Astoria Strategic Wealth Inc. lifted its holdings in Heart Test Laboratories, Inc. (NASDAQ:HSCS) by 246.1% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 81,995 shares of the company’s stock after acquiring an additional 58,303 shares during the quarter. Astoria Strategic Wealth Inc. owned 0.75% of Heart Test Laboratories worth $35,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 17.24% of the company’s stock.

Heart Test Laboratories Price Performance

Shares of HSCS stock remained flat at $0.10 during trading hours on Friday. 1,613,118 shares of the stock were exchanged, compared to its average volume of 2,779,883. The stock has a 50 day simple moving average of $0.12 and a two-hundred day simple moving average of $0.17. Heart Test Laboratories has a one year low of $0.09 and a one year high of $1.32. The firm has a market capitalization of $6.39 million, a price-to-earnings ratio of -0.20 and a beta of 3.44.

Heart Test Laboratories (NASDAQ:HSCS) last released its quarterly earnings data on Thursday, March 14th. The company reported ($0.03) EPS for the quarter. The firm had revenue of $0.02 million for the quarter.

Heart Test Laboratories Company Profile

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.